Prognosis Analysis and Validation of m6A Signature and Tumor Immune Microenvironment in Glioma

In conclusion, we construct a novel prognostic model which provides new insights into glioma prognosis. The PDPN and TIMP1 may serve as potential biomarkers for prognosis of glioma.
Source: Frontiers in Oncology - Category: Cancer & Oncology Source Type: research